Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.47164 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.45433 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.8223 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.40528 | 57 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.40163 | 57 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.49469 | 56 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.45317 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.43581 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.43187 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.44099 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.43694 | 57 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.42735 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.40182 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.44319 | 57 |